Disseminated bacillus Calmette-Guérin infection and immunodeficiency [14]

Emerging Infectious Diseases

Volumn 13, Issue 5, 2007, Pages 799-801

  Bernatowska, Ewa Anna ^a   Wolska Kusnierz, Beata ^a   Pac, Malgorzata ^a   Kurenko Deptuch, Magdalena ^a   Zwolska, Zofia ^b   Casanova, Jean Laurent ^c   Piatosa, Barbara ^a   Van Dongen, Jacques ^d   Roszkowski, Kazimierz ^b   Mikoluc, Bozena ^e   Klaudel Dreszler, Maja ^a   Liberek, Anna ^e  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CIPROFLOXACIN; ISONIAZID; RIFAMPICIN;

BACTERIAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INFECTION; INJECTION SITE INFLAMMATION; LETTER; MORTALITY; OSTEOMYELITIS; PATHOGENESIS; TUBERCULOMA; TUBERCULOSIS; VACCINATION;

EID: 34247847805     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1305.060865     Document Type: Letter

References (10)

1. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996;335:1941-9.
2. Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection. Lancet. 1995;346:581.
3. Casanova JL, Blanche S, Emile JF, Jouanguy E, Lamhamedi S, Altare F, et al. Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study. Pediatrics. 1996;98:774-8.
4. Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, et al. Low penetrance, broad resistance, and favourable outcome of interleukin 12 receptor β1 deficiency: medical and immunogical implications. J Exp Med. 2003;197:527-35.
5. Liberek A, Korzon M, Bernatowska E, Kurenko-Deptuch M, Rydlewska M. Vaccination-related Mycobacterium bovis BCG infection. Emerg Infect Dis. 2006;12:860-2.
6. Heyderman RS, Morgan G, Levinsky R, Strobel S. Successful bone marrow transplantation and treatment of BCG infection in two patients with severe combined immunodeficiency. Eur J Pediatr. 1991;150:477-80.
7. Gonzalez B, Moreno S, Burdach R, Valenzuela MT, Herinquez A, Ramos MI. Clinical presentation of bacillus Calmette-Guérin infections in patients with immunodeficiency syndromes. Pediatr Infect Dis J. 1989;8:201-6.
8. Wolska-Kusnierz B, Pac M, Pietrucha B, Heropolitanska-Pliszka E, Klaudel-Dreszler M, Kurenko-Deptuch M, et al. Twenty five years of investigation into primary immunodeficiency diseases in the Department of Immunology, Children's Memorial Health Institute, Warsaw. Central European Journal of Immunology. 2005;30:104-14 [cited 2007 Mar 19]. Available from http://www.termedia.pl/magazine.php?magazine_id=10&article_id= 6799&magazine_subpage=ABSTRACT.
9. Bonilla FA, Bernstein IL, Khan DA, Ballas ZJ, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and the management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94 (5 Suppl 1):S1-63.
10. Folb PI, Bernatowska E, Chen R, Clemens J, Dodoo AN, Ellenberg SS, et al. A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. Am J Public Health. 2004;94:1926-31. 801-802